精准7T生物反馈靶向多巴胺能中脑治疗抑郁症:原理验证随机对照试验
该原理验证随机对照试验将62名未用药的抑郁症患者和健康对照随机分配接受活性或假7T功能磁共振生物反馈,靶向动机调节。活性组抑郁症患者在训练后即刻和24小时临床改善因子显著优于假组,但7天和30天随访时效果不再显著;抑郁心境和负性情感改善最明显,且VTA与外侧额叶皮层功能耦合增强,VTA调节程度与临床改善相关。
要点
- 7T功能磁共振生物反馈靶向多巴胺能中脑可短期改善抑郁症患者抑郁心境和负性情感。
- 活性生物反馈组临床改善在训练后即刻和24小时显著优于假组,但7天和30天随访效果减弱且不显著。
- VTA与外侧额叶皮层功能耦合增强,且VTA调节程度与临床改善相关。
核心结论
- 多巴胺能中脑生物反馈训练对改善抑郁症患者心境和负性情感具有潜在效用。
研究设计与样本
- 随机对照原理验证试验,共纳入62名未用药的抑郁症患者和健康对照,随机接受活性或假7T功能磁共振生物反馈,临床评估至训练后30天。
主要发现
- 活性组抑郁症患者相比假组在训练后即刻临床改善因子显著改善(β=15.85,t=2.31,p=0.03),训练后24小时亦显著(β=22.84,t=2.45,p=0.02)。
- 7天和30天随访时效果减弱且不再显著。
- 抑郁心境(F=5.04,p=0.029)和负性情感(F=5.21,p=0.027)改善最明显,正性情感未显著改善。
- 活性生物反馈训练随时间增强抑郁症患者VTA与外侧额叶皮层的功能耦合(F=6.03,p=0.017),且VTA总体调节程度与临床改善相关(R=0.268,p=0.048)。
临床怎么用
- 该原理验证结果提示基于多巴胺能中脑的生物反馈训练可能作为改善抑郁症患者心境和负性情感的干预方向,但需进一步验证长期效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The significant heterogeneity of major depressive disorder (MDD) requires the development of interventions that directly target underlying cognitive or neurobiological mechanisms. This work tested the efficacy of self-modulation of the dopaminergic midbrain with high-field 7-Tesla functional MRI biofeedback in a randomized, controlled, proof-of-principle trial that targeted motivation regulation. A total of N = 62 unmedicated participants (MDD and healthy controls) were randomized to receive either Active or Sham 7-Tesla functional MRI biofeedback and completed clinical assessments pre- and up to 30-days post-training. Factor analysis of clinical symptom change revealed a single latent clinical improvement factor that was significantly improved in the Active MDD compared to the Sham MDD group, immediately post-training (β = 15.85, t = 2.31, p = 0.03), and at 24-hours post-training (β = 22.84, t = 2.45, p = 0.02); effects were diminished and no longer significant at 7-day and 30-day follow-ups. Results of specific phenotypic clinical analysis revealed that depressed mood (F = 5.04, p = 0.029) and negative affect (F = 5.21, p = 0.027), but not positive affect, were most improved by the Active biofeedback intervention. Active biofeedback training engaged functional coupling over time between the VTA and the lateral frontal cortex in the MDD group (F = 6.03, p = 0.017), and greater overall VTA regulation was associated with clinical improvement (R = 0.268, p = 0.048). Together, these results indicate the potential utility of dopaminergic midbrain-based biofeedback training for improvement of mood and negative affect in MDD.
引用
- Morris LS, Beltrán JM, Kvamme TL, et al. Targeting the dopaminergic midbrain with precision 7-Tesla biofeedback training in depression: A proof-of-principle randomized controlled trial. Mol Psychiatry. 2026. PMID: 42763338. doi:10.1038/s41380-026-03911-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。